On ECHEMI
Home > Drugs > Lymphocytic leukemia
Lymphocytic leukemia
There are two types of lymphocytic leukemia, one is acute lymphocytic leukemia and the other is chronic lymphocytic leukemia. Acute lymphocytic leukemia is a progressive malignant disease characterized by a large number of immature white blood cells similar to lymphoblasts. These cells can be found in the blood, bone marrow, lymph nodes, spleen and other organs. Chronic lymphocytic leukemia, referred to as CLL, is a malignant proliferative disease of lymphocytes in certain immune-deficient lymphocytes in the lymphocyte system with a slow onset. This disease is rare in my country, accounting for only 3.4% of leukemia, and is more common in Caucasians in Europe and America, accounting for 25-30%. The age of onset is mostly over 50 years old, and it is rare for those under 30 years old. There are more men than women. The main manifestations are systemic lymphadenopathy, splenomegaly, anemia and abnormal increase in lymphocytes in peripheral blood.
Related Drugs
Imatinib Mesylate Tablets
Indication: It is used to treat the chronic phase, accelerated phase or blast phase of Philadelphia chromosome-positive chronic myeloid leukemia (PhCML). (See the inner package insert for details).
Manufacturer:

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Imatinib Mesylate Capsules
Indication: For the treatment of chronic phase, accelerated phase or blast phase of Philadelphia chromosome-positive chronic myeloid leukemia (PhCML); for the treatment of adult patients with unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST). The safety and efficacy information for the following indications mainly comes from foreign research data, and the data for the Chinese population is limited: 1. For the treatment of adult relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (PhALL). 2. For the treatment of adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) accompanied by FIP1L1-PDGFRα fusion kinase. 3. For the treatment of myelodysplastic syndrome/myeloproliferative disease (MDS/MPD) accompanied by platelet-derived
Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:

Xi'an Disai Biopharmaceutical Co., Ltd.

Homoharringtonine for injection
Indication: This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:

Xi'an Disai Biopharmaceutical Co., Ltd.

Homoharringtonine Sodium Chloride Injection
Indication: It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Manufacturer:

Shandong Qidu Pharmaceutical Co., Ltd.

Homoharringtonine Sodium Chloride Injection
Indication: It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute myeloid leukemia. It also has certain effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia, and polycythemia vera.
Manufacturer:

Gansu Fuzheng Pharmeceutical SCI & Tech Co., Ltd.

Compound Cyclophosphamide Tablets
Indication: It is suitable for malignant lymphoma, multiple myeloma, lymphocytic leukemia, neuroblastoma, ovarian cancer, breast cancer, various sarcomas and lung cancer, etc.
Manufacturer:

Tonghua Mao Xiang Pharmaceutical Co., Ltd.

Compound Cyclophosphamide Tablets
Indication: Anti-tumor drug. Mainly used for malignant lymphoma, acute lymphoblastic leukemia, lung cancer, various sarcomas, solid tumors and ovarian cancer.
Manufacturer:

Jilin Jiatai Pharmaceutical Co., Ltd.

Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Homoharringtonine Injection
Indication: It is suitable for various types of acute non-lymphocytic leukemia, and also has certain therapeutic effects on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Manufacturer:

Yaopharma Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.